The association of SARS-CoV-2 infection (NeuroCOVID) with damage to the nervous system is not clearly understood. The non-exclusive mechanisms that can lead to NeuroCOVID can include invasion of the ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

It is not possible to test for a cerebrospinal fluid (CSF) leak at home. However, knowing the possible symptoms of a CSF leak can help a person know when to seek emergency help to receive a diagnosis ...

Scientists from the Max Planck Institute of Biochemistry and the Technical University of Munich have discovered new diagnostic markers of multiple sclerosis (MS) in cerebrospinal fluid (CSF). This was ...

Exploring the genetic blueprint of cerebrospinal fluid proteins, this study uncovers new markers and therapeutic targets that may unlock advancements in Alzheimer’s diagnosis and care. Study: ...

Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 Effective diagnosis, prognostication, ...

In cerebrospinal fluid, titanium, niobium, and zirconium levels were significantly elevated, but only when serum levels of these metals were also increased. This is an important finding as it supports ...

They found that more than 3 in 4 individuals with post-COVID cognitive symptoms had abnormalities in their cerebrospinal fluid and that such abnormalities were absent in the control group. Most of the ...

Pharaoh Neuro’s cerebrospinal fluid management system has already demonstrated positive prospective trial results.

OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...